Iron supplement comparison for young children with anemia
Treatments studied
Part of Blood & lymphatic clinical trials.
This study compares two ways of giving iron to children aged 1 to 5 with moderate iron deficiency anemia. The goal is to see which method works better and is easier for families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 12 and 59 months old (1 to just under 5 years old).
- Your child must have moderate iron deficiency anemia, with a hemoglobin level between 7 and 9.9 g/dL.
- You (as parent or guardian) must be willing to give informed consent for your child to participate.
- Your child must not have severe anemia (hemoglobin below 7 g/dL), which might require a blood transfusion.
- Your child must not have a known blood disorder like thalassemia, an active severe infection, or have had iron therapy in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two iron medicines—one a simple iron pill and the other a gentle iron form—to see which works better for children with low iron levels (anemia). If your child has iron deficiency anemia and none of the listed health issues, they may be able to join.
This trial studies whether taking iron by mouth can improve iron levels and anemia (low red blood cell counts) in children with chronic kidney disease. It may help reduce fatigue and support normal blood-making, by comparing different approaches for children who meet specific iron test results.
This study tests whether a special young child formula can help improve iron levels in children ages 1 to 3 who are either healthy or have mild anemia. It may help prevent or manage low iron without needing supplements.
This study compares two IV iron treatments—ferumoxytol and iron sucrose—to treat iron deficiency anemia in children with chronic kidney disease. It aims to see which option works better and is safe, and also to learn how each medicine behaves in the body.
This trial studies IV ferric derisomaltose to treat iron deficiency anemia in children under 18. It is meant for children whose anemia is from a true iron problem and who either cannot tolerate or do not respond to iron taken by mouth, or have certain kidney-related causes.
This trial compares taking iron every day versus every other day to see which works better for children with iron deficiency anemia. It may help find a simpler or more effective way to treat this condition.
Hear when a new Iron Deficiency Anemia in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.